Found 6 matching trials
Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly
NAThe main purpose of this study is to test if brentuximab vedotin has an eff...
Location
Multiple Locations
Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC
N/AThis prospective, multicenter, real-world observational study aims to evalu...
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
PHASE1To evaluate the safety of therapeutic immunological agent against EBV-posit...
Status
Active Not Recruiting
Location
West China Hospital
Pembro Plus CAR T-cell Therapy in R/R in PMBCL
PHASE2This research study is evaluating the combination of drugs, pembrolizumab w...
Location
Dana-Farber Cancer Institute
Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
PHASE1This study intends to conduct a prospective single-center open single-arm m...
Location
West China Hospital
Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours
PHASE2The aim of the present investigation is to test of the modulation obtained ...
Location
ASST degli Spedali Civili di Brescia